Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

NCT07294677 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT07294677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07294677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
Lead sponsor
University of Chicago
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 17, 2026
Completion date
March 31, 2032
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma